BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9225939)

  • 1. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
    Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
    Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
    Adkins DR; Goodnough LT; Shenoy S; Brown R; Moellering J; Khoury H; Vij R; DiPersio J
    Blood; 2000 Jun; 95(11):3605-12. PubMed ID: 10828051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
    Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
    Bensinger WI; Price TH; Dale DC; Appelbaum FR; Clift R; Lilleby K; Williams B; Storb R; Thomas ED; Buckner CD
    Blood; 1993 Apr; 81(7):1883-8. PubMed ID: 7681705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.
    Andrews RG; Briddell RA; Knitter GH; Rowley SD; Appelbaum FR; McNiece IK
    Blood; 1995 Jan; 85(1):15-20. PubMed ID: 7528562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
    Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
    Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation.
    Lapierre V; Aupérin A; Tayebi H; Chabod J; Saas P; Michalet M; François S; Garban F; Giraud C; Tramalloni D; Oubouzar N; Blaise D; Kuentz M; Robinet E; Tiberghien P;
    Blood; 2002 Aug; 100(4):1484-9. PubMed ID: 12149235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR; Ji SQ; Wang HX; Yan HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection.
    Clarke K; Szer J; Shelton M; Coghlan D; Grigg A
    Bone Marrow Transplant; 1995 Nov; 16(5):723-6. PubMed ID: 8547874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study.
    Dignani MC; Anaissie EJ; Hester JP; O'Brien S; Vartivarian SE; Rex JH; Kantarjian H; Jendiroba DB; Lichtiger B; Andersson BS; Freireich EJ
    Leukemia; 1997 Oct; 11(10):1621-30. PubMed ID: 9324280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
    Singh AD; Parmar S; Patel K; Shah S; Shore T; Gergis U; Mayer S; Phillips A; Hsu JM; Niesvizky R; Mark TM; Pearse R; Rossi A; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):288-293. PubMed ID: 29061534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.
    Liles WC; Huang JE; Llewellyn C; SenGupta D; Price TH; Dale DC
    Transfusion; 1997 Feb; 37(2):182-7. PubMed ID: 9051093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients.
    Couban S; Messner HA; Andreou P; Egan B; Price S; Tinker L; Meharchand J; Forrest DL; Lipton J
    Biol Blood Marrow Transplant; 2000; 6(4A):422-7. PubMed ID: 10975510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyethylstarch sedimentation by gravity ex vivo for red cell reduction of granulocyte apheresis components.
    Adkins D; Johnston M; Walsh J; Spitzer G; Goodnough T
    J Clin Apher; 1998; 13(2):56-61. PubMed ID: 9704606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
    Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S
    Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.